Safety and Performance Study of the Siello S Pacing Lead
Public ClinicalTrials.gov record NCT01791127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the SIELLO study is to demonstrate the safety and effectiveness of the BIOTRONIK Siello S pacing lead.
Study identification
- NCT ID
- NCT01791127
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,758 participants
Conditions and interventions
Interventions
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2013
- Primary completion
- Apr 16, 2019
- Completion
- Apr 16, 2019
- Last update posted
- May 31, 2020
2013 – 2019
United States locations
- U.S. sites
- 53
- U.S. states
- 24
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | La Jolla | California | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Stamford | Connecticut | — | — |
| Not listed | Plantation | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Cumming | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Jerseyville | Illinois | — | — |
| Not listed | Park Ridge | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Grand Blanc | Michigan | — | — |
| Not listed | Warren | Michigan | — | — |
| Not listed | Ypsilanti | Michigan | — | — |
| Not listed | Tupelo | Mississippi | — | — |
| Not listed | Cape Girardeau | Missouri | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Bridgewater | New Jersey | — | — |
| Not listed | Haddon Heights | New Jersey | — | — |
| Not listed | Flushing | New York | — | — |
| Not listed | Concord | North Carolina | — | — |
| Not listed | Fargo | North Dakota | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Middletown | Ohio | — | — |
| Not listed | Steubenville | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Wynnewood | Pennsylvania | — | — |
| Not listed | Anderson | South Carolina | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Lancaster | South Carolina | — | — |
| Not listed | Rock Hill | South Carolina | — | — |
| Not listed | West Columbia | South Carolina | — | — |
| Not listed | Alice | Texas | — | — |
| Not listed | Bedford | Texas | — | — |
| Not listed | Orange | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Victoria | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Fredericksburg | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
| Not listed | Cheyenne | Wyoming | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01791127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2020 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01791127 live on ClinicalTrials.gov.